Pamela Woodard, MD, of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, discusses the challenges and benefits of being an early adopter of this technology.
[[{"type":"media","view_mode":"media_crop","fid":"8216","attributes":{"alt":"Siemens Biograph mMR PET/MR","class":"media-image media-image-left","id":"media_crop_4872934844629","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"217","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]Pioneering a new imaging technology is far more complicated than plugging it in and scanning patients. At the Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, implementing the Siemens Biograph mMR hybrid PET/MR system requires the radiologists to develop the protocols.
"It's a very new piece of equipment," said Pamela Woodard, MD, of the Center for Clinical Imaging Research (CCIR), Mallinckrodt Institute of Radiology, Washington University School of Medicine. "It's not like a CT scanner that everyone has been using for 35 years and you just start scanning."
Washington University School of Medicine is only the third site in the U.S. to have this equipment, with two other sites set to come online soon. Siemens received FDA 510(k) clearance in June 2011 for the Biograph mMR, the first system to allow for simultaneous whole-body scanning by MR and PET.
[[{"type":"media","view_mode":"media_crop","fid":"11970","attributes":{"alt":"Pamela Woodward","class":"media-image","id":"media_crop_590670178982","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"216","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]And despite the start-up challenges, the lower dose and the simultaneous scans provide some major benefits for patients, according to Woodard. In this podcast, Woodard explains how this technology is being used, why her institution became an early adopter, and what they've learned so far.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.